BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34363537)

  • 1. Decreased risk for substance use disorders in individuals with high-functioning autism spectrum disorder.
    Yule AM; DiSalvo M; Biederman J; Wilens TE; Dallenbach NT; Taubin D; Joshi G
    Eur Child Adolesc Psychiatry; 2023 Feb; 32(2):257-265. PubMed ID: 34363537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Everyday life consequences of substance use in adult patients with a substance use disorder (SUD) and co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD): a patient's perspective.
    Kronenberg LM; Slager-Visscher K; Goossens PJ; van den Brink W; van Achterberg T
    BMC Psychiatry; 2014 Sep; 14():264. PubMed ID: 25234344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment seeking adults with autism or ADHD and co-morbid substance use disorder: prevalence, risk factors and functional disability.
    Sizoo B; van den Brink W; Koeter M; Gorissen van Eenige M; van Wijngaarden-Cremers P; van der Gaag RJ
    Drug Alcohol Depend; 2010 Feb; 107(1):44-50. PubMed ID: 19786328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coping styles in substance use disorder (SUD) patients with and without co-occurring attention deficit/hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
    Kronenberg LM; Goossens PJ; van Busschbach J; van Achterberg T; van den Brink W
    BMC Psychiatry; 2015 Jul; 15():159. PubMed ID: 26169586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lifetime co-occurring psychiatric disorders in newly diagnosed adults with attention deficit hyperactivity disorder (ADHD) or/and autism spectrum disorder (ASD).
    Pehlivanidis A; Papanikolaou K; Mantas V; Kalantzi E; Korobili K; Xenaki LA; Vassiliou G; Papageorgiou C
    BMC Psychiatry; 2020 Aug; 20(1):423. PubMed ID: 32847520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using the Autism-spectrum quotient to discriminate Autism Spectrum Disorder from ADHD in adult patients with and without comorbid Substance Use Disorder.
    Sizoo BB; van den Brink W; Gorissen-van Eenige M; Koeter MW; van Wijngaarden-Cremers PJ; van der Gaag RJ
    J Autism Dev Disord; 2009 Sep; 39(9):1291-7. PubMed ID: 19396535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Need for care and life satisfaction in adult substance use disorder patients with and without attention deficit hyperactivity disorder (ADHD) or autism spectrum disorder (ASD).
    Kronenberg LM; Goossens PJ; van Etten DM; van Achterberg T; van den Brink W
    Perspect Psychiatr Care; 2015 Jan; 51(1):4-15. PubMed ID: 24410895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Personality characteristics of adults with autism spectrum disorders or attention deficit hyperactivity disorder with and without substance use disorders.
    Sizoo B; van den Brink W; Gorissen van Eenige M; van der Gaag RJ
    J Nerv Ment Dis; 2009 Jun; 197(6):450-4. PubMed ID: 19525746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low prevalence of risk drinking in adolescents and young adults with autism spectrum problems.
    Kaltenegger HC; Doering S; Gillberg C; Wennberg P; Lundström S
    Addict Behav; 2021 Feb; 113():106671. PubMed ID: 33080544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of Psychiatric Comorbidity and Genetic Correlations Provide New Insights Into Differences Between Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder.
    Solberg BS; Zayats T; Posserud MB; Halmøy A; Engeland A; Haavik J; Klungsøyr K
    Biol Psychiatry; 2019 Oct; 86(8):587-598. PubMed ID: 31182215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Decreased interoceptive accuracy in children with autism spectrum disorder and with comorbid attention deficit/hyperactivity disorder.
    Yang HX; Zhou HY; Li Y; Cui YH; Xiang Y; Yuan RM; Lui SSY; Chan RCK
    Autism Res; 2022 Apr; 15(4):729-739. PubMed ID: 35088528
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early-age clinical and developmental features associated to Substance Use Disorders in Attention-Deficit/Hyperactivity Disorder in Adults.
    Nogueira M; Bosch R; Valero S; Gómez-Barros N; Palomar G; Richarte V; Corrales M; Nasillo V; Vidal R; Casas M; Ramos-Quiroga JA
    Compr Psychiatry; 2014 Apr; 55(3):639-49. PubMed ID: 24411652
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gender Differences in Associations Between Attention-Deficit/Hyperactivity Disorder and Substance Use Disorder.
    Ottosen C; Petersen L; Larsen JT; Dalsgaard S
    J Am Acad Child Adolesc Psychiatry; 2016 Mar; 55(3):227-34.e4. PubMed ID: 26903256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ADHD severity as it relates to comorbid psychiatric symptomatology in children with Autism Spectrum Disorders (ASD).
    Mansour R; Dovi AT; Lane DM; Loveland KA; Pearson DA
    Res Dev Disabil; 2017 Jan; 60():52-64. PubMed ID: 27889487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does exposure to parental substance use disorders increase offspring risk for a substance use disorder? A longitudinal follow-up study into young adulthood.
    Yule AM; Wilens TE; Martelon M; Rosenthal L; Biederman J
    Drug Alcohol Depend; 2018 May; 186():154-158. PubMed ID: 29573650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substance use and nicotine dependence in persistent, remittent, and late-onset ADHD: a 10-year longitudinal study from childhood to young adulthood.
    Ilbegi S; Groenman AP; Schellekens A; Hartman CA; Hoekstra PJ; Franke B; Faraone SV; Rommelse NNJ; Buitelaar JK
    J Neurodev Disord; 2018 Dec; 10(1):42. PubMed ID: 30587104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychiatric Comorbidities and Psychotropic Medication Use in Autism: A Matched Cohort Study with ADHD and General Population Comparator Groups in the United Kingdom.
    Houghton R; Liu C; Bolognani F
    Autism Res; 2018 Dec; 11(12):1690-1700. PubMed ID: 30380202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic overlap and causality between substance use disorder and attention-deficit and hyperactivity disorder.
    Vilar-Ribó L; Sánchez-Mora C; Rovira P; Richarte V; Corrales M; Fadeuilhe C; Arribas L; Casas M; Ramos-Quiroga JA; Ribasés M; Soler Artigas M
    Am J Med Genet B Neuropsychiatr Genet; 2021 Apr; 186(3):140-150. PubMed ID: 33244849
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Whole Brain White Matter Tract Deviation and Idiosyncrasy From Normative Development in Autism and ADHD and Unaffected Siblings Link With Dimensions of Psychopathology and Cognition.
    Tung YH; Lin HY; Chen CL; Shang CY; Yang LY; Hsu YC; Tseng WI; Gau SS
    Am J Psychiatry; 2021 Aug; 178(8):730-743. PubMed ID: 33726525
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Attention deficit hyperactivity disorder (ADHD) symptoms, comorbid psychopathology, behaviour problems and gastrointestinal symptoms in children and adolescents with autism spectrum disorder.
    Leader G; Moore R; Chen JL; Caher A; Arndt S; Maher L; Naughton K; Clune R; Mannion A
    Ir J Psychol Med; 2022 Sep; 39(3):240-250. PubMed ID: 33973506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.